| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(08)61204-0 |
| P698 | PubMed publication ID | 18723218 |
| P50 | author | Sidney S Atwood | Q51739797 |
| P2093 | author name string | Paul E Farmer | |
| Jennifer J Furin | |||
| Joia S Mukherjee | |||
| Michael L Rich | |||
| Sonya S Shin | |||
| Salmaan Keshavjee | |||
| Sidney Atwood | |||
| Edward A Nardell | |||
| Aivar K Strelis | |||
| Sergey P Mishustin | |||
| Alexander D Pasechnikov | |||
| Irina Y Gelmanova | |||
| Yevgeny G Andreev | |||
| Jim Y Kim | |||
| P2860 | cites work | Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis | Q21563671 |
| Extensively drug-resistant tuberculosis, Italy and Germany | Q24658381 | ||
| Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru | Q28202372 | ||
| Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa | Q28272340 | ||
| Pulmonary resection for multi-drug resistant tuberculosis | Q33937213 | ||
| Increasing transparency in partnerships for health--introducing the Green Light Committee | Q34976025 | ||
| From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift | Q35132002 | ||
| Programmes and principles in treatment of multidrug-resistant tuberculosis | Q35666918 | ||
| Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru | Q36225653 | ||
| Worldwide emergence of extensively drug-resistant tuberculosis | Q37302822 | ||
| Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia | Q39415460 | ||
| Simultaneous infection with multiple strains of Mycobacterium tuberculosis | Q43712241 | ||
| Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis | Q44240902 | ||
| Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? | Q44312351 | ||
| Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries | Q44528463 | ||
| The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis | Q45115476 | ||
| Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease | Q45306776 | ||
| Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran | Q46981600 | ||
| Extensively Drug-Resistant Tuberculosis Is Worse than Multidrug-Resistant Tuberculosis: Different Methodology and Settings, Same Results | Q56833404 | ||
| Clinical and operational value of the extensively drug-resistant tuberculosis definition | Q56833417 | ||
| Transmission of Drug‐Resistant Tuberculosis among Treated Patients in Shanghai, China | Q60231557 | ||
| Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections | Q68060966 | ||
| Role of surgery in multi-drug-resistant tuberculosis: results of 27 cases | Q73881517 | ||
| P433 | issue | 9647 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Russia | Q159 |
| tuberculosis | Q12204 | ||
| extensively drug-resistant tuberculosis | Q1040214 | ||
| P304 | page(s) | 1403-1409 | |
| P577 | publication date | 2008-08-22 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study | |
| P478 | volume | 372 |
| Q34422228 | Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics |
| Q26830053 | All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease |
| Q26852644 | Alternative methods of diagnosing drug resistance--what can they do for me? |
| Q34101408 | Anti tuberculosis drug resistance in west of iran. |
| Q27013703 | Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis |
| Q34975537 | Averting epidemics of extensively drug-resistant tuberculosis |
| Q37783433 | Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis |
| Q34989566 | Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa |
| Q33760793 | Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis |
| Q53041364 | Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis |
| Q37065764 | Comparative Proteomic Analyses of Avirulent, Virulent, and Clinical Strains of Mycobacterium tuberculosis Identify Strain-specific Patterns |
| Q28486275 | Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia |
| Q42978707 | Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients |
| Q35705874 | Current development and future prospects in chemotherapy of tuberculosis |
| Q34065647 | Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment |
| Q37349855 | Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis |
| Q33595284 | Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge |
| Q37815427 | Drug-resistant tuberculosis: an insurmountable epidemic? |
| Q43058124 | Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study |
| Q34257441 | Evaluation of a novel biphasic culture medium for recovery of mycobacteria: a multi-center study |
| Q52707803 | Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care |
| Q44745196 | Extensively Drug-Resistant TB in Eastern Cape, South Africa: High Mortality in HIV-Negative and HIV-Positive Patients |
| Q34410451 | Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery |
| Q41376759 | Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management |
| Q30433414 | Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa |
| Q26830094 | Extensively drug-resistant tuberculosis: epidemiology and management |
| Q37785721 | Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals |
| Q34974217 | Fourth-generation fluoroquinolones in tuberculosis |
| Q42751543 | Global Impact of Multidrug-Resistant Pulmonary Tuberculosis Among HIV-Infected and Other Immunocompromised Hosts: Epidemiology, Diagnosis, and Strategies for Management |
| Q33926262 | Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis |
| Q28478841 | Health related quality of life among patients with tuberculosis and HIV in Thailand |
| Q37599981 | Health-Related Quality of Life, Depression and Anxiety in Hospitalized Patients with Tuberculosis |
| Q28546682 | High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis |
| Q34423664 | High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003. |
| Q58485192 | Household screening and multidrug-resistant tuberculosis |
| Q35008349 | Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death |
| Q85178196 | Ireland’s potential MDR-TB and XDR-TB problem |
| Q39355934 | Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study |
| Q38040155 | Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: Update 2012 |
| Q35990643 | Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes |
| Q34453683 | Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community |
| Q27003210 | New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid |
| Q36471055 | Nosocomial Transmission of Extensively Drug-Resistant Tuberculosis in a Rural Hospital in South Africa |
| Q36420040 | Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002–2005 |
| Q38971924 | Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study |
| Q28476641 | Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community |
| Q26774846 | Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review |
| Q37166699 | Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis |
| Q36273236 | Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine |
| Q28536653 | Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation |
| Q34290003 | Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model |
| Q26738605 | Surgery and pleuro-pulmonary tuberculosis: a scientific literature review |
| Q26999739 | Surgical treatment of drug-resistant tuberculosis |
| Q28481405 | Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa |
| Q35577316 | Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study |
| Q28551241 | The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia |
| Q28551772 | The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review |
| Q36047674 | The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis |
| Q56838220 | The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? |
| Q40055507 | Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city |
| Q34451895 | Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector |
| Q37196315 | Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa |
| Q37259517 | Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis (MDR- TB) Compared with Non-MDR-TB Infections in Peninsular Malaysia |
| Q46176164 | Treatment of extensively drug-resistant tuberculosis |
| Q83143310 | Treatment of extensively drug-resistant tuberculosis |
| Q33581286 | Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis |
| Q34952765 | Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis |
| Q61452100 | Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan |
| Q37589430 | Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies |
| Q47638862 | Treatment outcomes of multidrug-resistant tuberculosis in Taiwan: tackling loss to follow-up |
| Q28476110 | Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis |
| Q83143314 | Unsexy tuberculosis |
| Q60045628 | Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts |
| Q26852253 | WHO Group 5 Drugs and Difficult Multidrug-Resistant Tuberculosis: a Systematic Review with Cohort Analysis and Meta-Analysis |
| Q58485203 | XDR tuberculosis can be cured with aggressive treatment |
| Q46465504 | XDR tuberculosis in South Africa: old questions, new answers |
| Q37473011 | Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis |
Search more.